Vegran et al. previously showed that the addition of IL-1β to the classical TH9 cell differentiation conditions—IL-4 and TGFβ—promoted the expression of IL-9 and IL-21 and enhanced the anti-tumor properties of TH9 cells [38]. The gene discussed is IL1B; the disease is neoplasm.